Fig. 1From: The MRZ reaction helps to distinguish rheumatologic disorders with central nervous involvement from multiple sclerosisFrequency of positive MRZR-1 (≥ 1 positive AI) and MRZR-2 (≥ 2 positive AIs) in patients with rheumatologic disorders with involvement of the central nervous system (RDwCNS), multiple sclerosis (MS), and other inflammatory autoimmune neurological diseases (OIND; [17])Back to article page